Table I.
Proportion of HeLa cells in G1, S and G2 phases of the cell cycle following ellagic acid treatment.
Ellagic acid dose µM | ||||
---|---|---|---|---|
Cell cycle phase | Control | 10 | 20 | 30 |
G1 | 60.3±4.21 | 69.9±3.55a | 75.7±3.27a | 84.7±3.01a |
S | 8.44±0.39 | 9.65±0.61 | 8.71±0.41 | 7.56±0.37 |
G2 | 31.2±3.82 | 20.4±2.94a | 15.6±2.87a | 9.38±1.37a |
P<0.05 vs. the control group. All data are expressed as the mean ± standard deviation.